AcutaaS Chemicals has officially inaugurated Phase 1 of its new "State of the Art" manufacturing block dedicated to electrolyte additives and battery chemicals production at its Jhagadia facility on January 19, 2026. The company informed stock exchanges about this significant milestone under Regulation 30 of SEBI (LODR) Regulations, 2015. The new facility is expected to add 30% revenue to the company's annual production.

Facility Inauguration and Revenue Impact

The newly inaugurated Phase 1 manufacturing block is located at the company's existing Unit-III Jhagadia facility. This development follows the company's earlier intimation to exchanges dated December 11, 2024, regarding the upcoming facility expansion. The dedicated facility for battery chemicals production is projected to contribute significantly to the company's revenue growth.

Strategic Manufacturing Enhancement

This Phase 1 inauguration represents a significant step in AcutaaS Chemicals' expansion strategy in the battery chemicals segment. The dedicated manufacturing block for electrolyte additives and battery chemicals positions the company to capitalize on the growing demand in the battery technology sector. The facility is strategically located at the existing Jhagadia complex, leveraging the company's established infrastructure and operational expertise.

Regulatory Compliance and Disclosure

AcutaaS Chemicals has fulfilled its regulatory obligations by informing both stock exchanges about the facility inauguration. The intimation was made pursuant to Regulation 30 and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has made the inauguration details available on its official website at www.acutaas.com , ensuring transparency and accessibility of information for all stakeholders.

Production Capacity Enhancement

The new manufacturing block dedicated to battery chemicals production represents a substantial enhancement to the company's production capabilities. With the potential to add 30% revenue to annual production, this facility inauguration marks a strategic milestone in AcutaaS Chemicals' growth trajectory in the specialized chemicals sector. Company Secretary & Compliance Officer CS Ekta Kumari Srivastava signed the official communication to the stock exchanges.

Acutaas Chemicals Limited , a prominent player in the chemical industry, has received a significant boost to its financial standing. CARE Ratings has reaffirmed the company's credit rating while simultaneously increasing its bank facilities, signaling strong confidence in the firm's operational and financial performance.

Credit Rating Reaffirmation

CARE Ratings has maintained Acutaas Chemicals' long-term and short-term bank facilities rating at CARE A4 Stable/CARE A1+. This reaffirmation comes after a review of the company's operational and financial performance.

Enhanced Bank Facilities

CARE Ratings has approved an increase in the company's bank facilities from Rs. 125.00 crores to Rs. 135.00 crores. This enhancement reflects the company's growing financial needs and its ability to manage larger credit lines.

Banking Partners

The enhanced bank facilities are spread across multiple banking partners, including:

Financial Performance Insights

An analysis of Acutaas Chemicals' balance sheet reveals significant growth and financial stability:

The company has demonstrated robust growth across key financial metrics, with total assets increasing by 43.55% year-over-year and total equity nearly doubling with a 94.28% increase. The significant reduction in current liabilities by 25.69% further underscores the company's improving financial health.

Conclusion

The credit rating reaffirmation and enhanced bank facilities are testament to Acutaas Chemicals' strong financial position and growth trajectory. As the company continues to expand its operations and strengthen its market presence, these developments may provide a solid foundation for future growth and investment opportunities.